Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes 1

Journal of Immunology

Volumn 156, Issue 7, 1996, Pages 2517-2521

  Bhardwaj, Ranjit S ^a   Schwarz, Agatha ^a   Becher, Eva ^a   Mahnke, Karsten ^a   Aragane, Yoshinori ^a   Schwarz, Thomas ^a   Luger, Thomas A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROOPIOMELANOCORTIN;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; MONOCYTE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; T LYMPHOCYTE ACTIVATION;

ALPHA-MSH; AMINO ACID SEQUENCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; MONOCYTES; PEPTIDE FRAGMENTS; PRO-OPIOMELANOCORTIN; RNA, MESSENGER; UP-REGULATION;

EID: 0029878041     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Blalock, J. E. 1994. The syntax of immune-neuroendocrine communication. Immunol. Today 15:504.
2. Reichlin, S. 1993. Neuroendocrine-immune interactions. N. Engl. J. Med. 329: 1246.
3. Dardenne, M., and W. Savino. 1994. Control of thymus physiology by peptidic hormones and neuropeptides. Immunol. Today 15:518.
4. Nio, D. A., R. N. Moylan, and J. K. Roche. 1993. Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements. J. Immunol. 150:5281.
5. Khansari, A., A. J. Murgo, and R. E. Faith. 1990. Effects of stress on the immune system. Immunol. Today 11:170.
6. Johnston, J. A., D. D. Taub, A. R. Lloyd, K. Conlon, J. J. Oppenheim, and D. J. Kevlin. 1994. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J. Immunol. 153:1762.
7. Iwamoto, I., S. Tomoe, H. Tomioka, and S. Yoshida. 1992. Substance P-induced granulocyte infiltration in mouse skin: the mast cell-dependent granulocyte infiltration by the N-terminal peptide is enhanced by the activation of vascular endothelial cells by the C-terminal peptide. Clin. Exp. Immunol. 87:203.
8. Hosoi, J., G. F. Murphy, C. L. Egan, E. A. Lerner, S. Grabbe, A. Asahina, and R. D. Granstein. 1993. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363:159.
9. Asahina, A., J. Hosoi, S. Beissert, A. Stratigos, and R. D. Granstein. 1995. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J. Immunol. 154:3056.
10. Catania, A., and J. M. Lipton. 1993. α-Melanocyte stimulating hormone in the modulation of host reactions. Endocr. Rev. 14:564.
11. Bhardwaj, R. S., and T. A. Luger. 1995. Pro-opiomelanocortin production by epidermal cells: evidence for an immune neuro-endocrine network in the epidermis. Arch. Dermatol. Res. 287:85.
12. Eberle, A. N. 1988. The Melanotropins. Karger, Basel, Switzerland.
13. Burbach, J. P. H., and V. M. Wiegant. 1990. Gene expression, biosynthesis, and processing of pro-opiomelanocortin peptides and vasopressin. In Neuropeptides: Basics and Perspectives. D. de Wied, ed. Elsevier, Amsterdam, p. 45.
14. Schauer, E., F. Trautinger, A. Köck, R. S. Bhardwaj, M. Simon, A. Schwarz, J. C. Ansel, T. Schwarz, and T. A. Luger. 1994. Pro-opiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J. Clin. Invest. 93: 2238.
15. Daynes, R. A., B. A. Robertson, B. H. Cho, D. K. Burnham, and R. Newton. 1987. α-Melanocyte stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin-1-inducible responses in vivo and in vitro. J. Immunol. 139:103.
16. Cannon, J. G., J. B. Tatro, S. Reichlin, and C. A. Dinarello. 1986. α-Melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin-1. J. Immunol. 137:2232.
17. Smith, E. M., T. K. J. Hughes, F. Hashemi, and G. B. Stefano. 1992. Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 89:782.
18. Chowdrey, H. S., S. L. Lightman, M. S. Harbuz, P. J. Larsen, and D. S. Jessop. 1994. Contents of corticotropin-releasing hormone and arginine vasopressin immunoreactivity in the spleen and thymus during a chronic inflammatory stress. J. Neuroimmunol. 53:17.
19. Rheins, L. A., A. L. Cotleur, R. S. Kleier, W. B. Hoppenjans, D. N. Sauder, and J. J. Nordlund. 1989. α-Melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J. Invest. Dermatol. 93:511.
20. Grabbe, S., R. S. Bhardwaj, M. Steinert, K. Mahnke, M. M. Simon, T. Schwarz, and T. A. Luger. 1996. α-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J. Immunol. 156:473.
21. Hiltz, M. E., and J. M. Lipton. 1990. α-Melanocyte stimulating hormone peptides inhibit acute inflammation and contact sensitivity. Peptides 11:979.
22. Howard, M., and A. O'Garra. 1992. Biological properties of interleukin-10. Immunol. Today 13:198.
23. Bhardwaj, R. S., C. Zotz, G. Zwadlo Klarwasser, J. Roth, M. Goebeler, K. Mahnke, M. Falk, G. Meinardus Hager, and C. Sorg. 1992. The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions. Eur. J. Immunol. 22:1891.
24. Kirnbauer, R., A. Köck, T. Schwarz, A. Urbanski, J. Krutmann, W. Borth, D. Damm, G. Shipley, J. C. Ansel, and T. A. Luger. 1989. IFN-β2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J. Immunol. 142: 1922.
25. Feinberg, A. P., and P. A. Vogelstein. 1983. A techique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6.
26. Hiltz, M. E., and J. M. Lipton. 1989. Anti-inflammatory activity of a COOH-terminal fragment of the neuropeptide α-MSH. FASEB J. 3:2282.
27. Robertson, B., K. Dostal, and R. A. Daynes. 1988. Neuropeptide regulation of inflammatory and immunologic responses. The capacity of α-melanocyte stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. J. Immunol. 140:4300.
28. Luger, T. A., E. Schauer, F. Trautinger, J. Krutmann, J. Ansel, A. Schwarz, and T. Schwarz. 1993. Production of immunosuppressing melanotropins by keratinocytes. Ann. NY Acad. Sci. 680:567.
29. Hiltz, M. E., A. Catania, and J. M. Lipton. 1992. α-Melanocyte stimulating hormone peptides inhibit acute inflammation induced in mice by rIL-1β, rIL-6, rTNF-α, and endogenous pyrogen but not that caused by LTB4, PAF, and rIL-8. Cytokine 4:320.
30. Mugridge, K. G., M. Perretti, P. Ghiara, and L. Parente. 1991. α-Melanocyte stimulating hormone reduces interleukin-1β effects on rat stomach preparations possibly through interference with a type I receptor. Eur. J. Pharmacol. 197:151.
31. Del Prete, G., M. De Carli, F. Almerigogna, M. G. Giudizi, R. Biagiotti, and S. Romagnani. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353.
32. Bhardwaj, R. S., E. Becher, K. Mahnke, T. Schwarz, and T. A. Luger. 1995. Modulation of α-melanocyte stimulating hormone receptor expression on human monocytes. J. Invest. Dermatol. 104:651.
33. Star, R. A., N. Rajora, J. Huang, R. Chavez, A. Catania, and J. M. Lipton. 1995. Evidence of autocrine modulation of macrophage nitric oxide synthase by α-MSH. Proc. Natl. Acad. Sci. USA 92:8016.
34. Platzer, C., Ch. Meisel, K. Vogt, M. Platzer, and H. D. Volk. 1995. Upregulation of monocyte IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 7:517.
35. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815.
36. Chang, C. H., M. Furue, and K. Tamaki. 1995. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by interleukin-10. Eur. J. Immunol. 25:394.
37. Willems, F., A. Marchant, J. P. Delville, C. Gerard, A. Delvaux, T. Velu, M. de Boer, and M. Goldman. 1994. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol. 24:1007.
38. Aebischer, I., M. R. Stämpfli, A. Zürcher, S. Miescher, A. Urwyler, B. Frey, T. A. Luger, R. R. White, and B. M. Stadler. 1994. Neuropeptides are potent modulators of human in vitro immunoglobulin E synthesis. Eur. J. Immunol. 24:1908.
39. Aebischer, I., M. Stämpfli, S. Miescher, M. Horn, A. W. Zürcher, and B. M. Stadler. 1996. Neuropeptides accentuate interleukin-4-induced human immunoglobulin E synthesis in vitro. Exp. Dermatol. 5:38.
40. Punnonen, J., R. de Waal Malefyt, P. van Vlasselaer, J. F. Gauchat, and J. E. de Vries. 1993. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J. Immunol. 151:1280.
41. Cassatella, M. A., L. Meda, S. Gasperini, F. Calzetti, and S. Bonora. 1994. Interleukin-10 (IL-10) up-regulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J. Exp. Med. 179:1695.
42. Enk, A. H., J. Saloga, D. Becker, M. Mohamadzadeh, and J. Knop. 1994. Induction of hapten-specific tolerance by interleukin-10 in vivo. J. Exp. Med. 179: 1397.
43. Schwarz, A., S. Grabbe, H. Riemann, Y. Aragane, M. Simon, S. Manon, S. Andrade, T. A. Luger, A. Zlotnik, and T. Schwarz. 1994. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J. Invest. Dermatol. 103:211.
44. Llorente, L., W. Zou, Y. Levy, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, B. Morel-Fourrier, J. C. Brouet, D. Alarcon-Segovia, P. Galanaud, and D. Emilie. 1995. Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181:839.
45. Cush, J. J., J. B. Splawski, R. Thomas, J. E. McFarlin, H. Schulze Koops, L. S. Davis, K. Fujita, and P. E. Lipsky. 1995. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 38:96.
46. Enk, C. D., D. Sredni, A. Blauvelt, and S. I. Katz. 1995. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J. Immunol. 154:4851.
47. Grewe, M., K. Gyufko, and J. Krutmann. 1995. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J. Invest. Dermatol. 104:3.
48. Kalled, S. L., N. Siva, H. Stein, and E. L. Reinherz. 1995. The distribution of CD10 (NEP 24.11, CALLA) in humans and mice is similar in non-lymphoid organs but differs within the hemopoietic system: absence on murine T and B lymphoid progenitors. Eur. J. Immunol. 25:677.
49. Deschodt Lanckman, M., Y. Vanneste, B. Loir, A. Michel, A. Libert, G. Ghanem, and F. Lejeune. 1990. Degradation of α-melanocyte stimulating hormone by CALLA/endopeptidase 24.11 expressed by human melanoma cells in culture. Int. J. Cancer 46:1124.
50. Tran Paterson, R., G. Boileau, V. Giguere, and M. Letarte. 1990. Comparative levels of CALLA/neutral endopeptidase on normal granulocytes, leukemic cells, and transfected COS-1 cells. Blood 76:775.